Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters

Information

  • Patent Grant
  • 11033190
  • Patent Number
    11,033,190
  • Date Filed
    Tuesday, February 25, 2020
    4 years ago
  • Date Issued
    Tuesday, June 15, 2021
    3 years ago
Abstract
A catheter system for optical coherence tomography includes an elongate catheter body, an optical fiber in the elongate catheter body, and an anamorphic lens assembly coupled with a distal end of the optical fiber. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the lens assembly.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


FIELD

Described herein are imaging devices and systems for use in biological probes. In particular, described herein are catheter-based imaging systems using Optical Coherence Tomography (OCT) having a molded lens adapted to minimize parasitic back-reflections and provide superior distance imaging and beam diameter characteristics.


BACKGROUND

A number of vascular diseases, such as coronary artery disease and peripheral vascular disease, are caused by the build-up of atherosclerotic deposits (plaque) in the arteries, which limit blood flow to the tissues that are supplied by that particular artery. Disorders caused by occluded body vessels, including coronary artery disease (CAD) and peripheral artery disease (PAD), may be debilitating and life-threatening. Chronic Total Occlusion (CTO) can result in limb gangrene, requiring amputation, and may lead to other complications and eventually death. Increasingly, treatment of such blockages may include interventional procedures in which a guidewire is inserted through a catheter into the diseased artery and threaded to the blocked region. There the blockage may be either expanded into a more open position, for example, by pressure from an inflated catheter balloon (e.g., balloon angioplasty) and/or the blocked region may be held open by a stent. Treatment of such blockages can also include using a catheter to surgically remove the plaque from the inside of the artery (e.g., an atherectomy).


There is medical interest in equipping catheters with sensors that can help direct the catheter for atherectomy, occlusion-crossing, and/or other surgical procedures. For example, it would be useful to have sensors that can give the surgeon immediate visual feedback as to whether a particular tissue is diseased and/or how far away the cutting portion of a catheter is from the boundary of a particular blood vessel layer to minimize the risk of accidental damage. Conventional radiological imaging methods and ultrasound imaging systems have been attempted for such surgical procedures. However, neither ultrasound nor radiological imaging methods have enough resolution to help guide the operation of the catheter through small dimensions. Moreover, standard radiological techniques cannot easily discriminate between healthy tissue and diseased tissue unless the tissue has become heavily calcified. Further, the components of an ultrasound system are generally too large to implement on a small scale, such as with a system configured to be used within blood vessels.


Optical Coherence Tomography (OCT) has been proposed as one technique that may be particularly helpful for imaging regions of tissue, including within a body lumen such as a blood vessel. At a basic level, OCT relies on the fact that light traveling from a source and scattering from more distant objects takes longer to travel back than light scattering from nearby objects. Due to the wave nature of light, very small timing differences caused by light signals traveling different distances on the micron scale can cause constructive or destructive interference with reference light signals. OCT systems measure the resulting interference to obtain an image of the target. A typical OCT system requires one or more interferometers to distinguish the signal from the applied light. In addition, most known OCT systems, when applied to catheters, include a fiber that is rotated (often at high rates) within the catheter in order to scan the lumen and a second, large reference arm.


A typical OCT device includes a target arm and a reference arm to generate a reference signal. In order to provide the interference reference signal, the OCT device will split an illuminating light signal from the source in two equal or unequal parts, send part of the illuminating light to the target of interest through one target optical “target arm” and send the other part of the illuminating light down a separate reference arm. Light from the separate reference arm reflects off of a mirror, and then returns and interferes with the scattered light that is returning from the target optical arm after bouncing off of the target. In a traditional OCT device, the reference arm length is engineered to be exactly the same length as the target arm so that the interference effect is maximized. The resulting interference between the two beams creates interference that can be measured to extract depth information related to the target. Using this depth information, an image of the object can be generated. A typical OCT device can further include a focusing lens in the target arm, such as a graded index (GRIN) lens, configured to focus the light coming out of the optical fiber into the tissue.


These traditional OCT systems, however, are large and cumbersome due to the required reference arm and are therefore generally ineffective for use in a medical catheter, particularly for use with a low cost and disposable catheter. Using a common path OCT system, i.e., a system without a separate reference arm, is one way to eliminate the cost and size of such an imaging catheter. There are several challenges, however, associated with developing a catheter having common path OCT. For example, a common path OCT system requires that the reference reflection be formed within the same optical conduit as the target reflection. This reference reflection must be finely tuned to avoid noise in the system, requiring that the path from the light source to the reflection interface be free of unnecessary components, such as focusing elements that could interfere with the reference reflection. Further, the common path system must have components that are small enough to fit inside of a single small catheter, making it difficult to include additional components. Finally, for common path OCT, it is desirable to have the reference reflection as close to the tissue as possible to maintain the imaging range within the coherence length of the source and avoid data processing burden, as data processed for the distance between the reference and the start of the imaging is not useful. Accordingly, a common path OCT system that solves some of these problems is desired.


The distal imaging tip of a common-path OCT catheter should perform two main functions: (1) direct the beam towards the imaging object and (2) focus the beam on the imaging object for improved image quality. In addition, for common path OCT, the geometry and properties of the distal imaging assembly should be such that it introduces only one primary source of back-reflection (reference reflection) and avoid any other parasitic reflection which could causes artifacts in the images.


One way to address these needs that has been proposed (see, e.g., US-2015-0099984) which uses a common-path OCT system with a graded index (GRIN) fiber attached to the distal tip of a single mode optical fiber in the catheter so as to act as a lens for focusing light. Unfortunately, this solution has proven problematic. For example, the addition of any lens (e.g., a graded index (GRIN) lens) is difficult and results in potential failure modes. FIG. 1 illustrates a prior-art device 100, such as a catheter, having housing 109 holding a graded index (GRIN) fiber 103 at the end of an optical fiber 110, forming a grins lens assembly. In this example, deflection and focusing of the beam is accomplished using two separate components. First, a mirror 101 is mounted at 45 degrees to the axis of the optical fiber 110 to deflect the beam perpendicular to axis of the catheter, as shown by beam 113. Second, the graded index fiber 103 is spliced to the optical fiber 110, which is a single mode fiber (SMF) assembly, in order to focus the beam. The GRIN fiber 103 is spliced in front of the SMF fiber 110 and then cleaved to precise length and angle to meet the focusing and reference reflection requirements in conjunction with the epoxy 102 used to secure the GRIN fiber 103 at the distal tip. The precision splicing and cleaving requirements for this SMF-GRIN assembly makes it an expensive component for the device 100.


Further, the manufacturing processes required to make these SMF-GRIN assemblies, such as that in device 100, is often difficult and requires precision alignment. Moreover, in order to splice the GRIN fiber 103 in front of the SMF fiber 110, the SMF fiber must be stripped to certain length (see stripped section 105 in FIG. 1). Stripping of the fiber SMF fiber, especially polyimide fibers, typically renders a long fragile portion 132 of fiber. The total length of the fragile portion 132 of the SMF-GRIN assembly may be greater than 2.5 mm. This fragile portion 132 often must be encapsulated inside a solid hypo tube, to prevent the distal portion from breaking while subjected to stress/strain while imaging in tortuous anatomy. The presence of the long (e.g., >2.5 mm) hypo tube in the device 100 reduces the flexibility of the distal tip. Thus, when the device 100 is part of a catheter, such as an atherectomy catheter, this reduced flexibility can make it difficult to access the tortuous section of the anatomy.


Moreover, focusing length may be sacrificed by using a GRIN fiber 103 and separate mirror 101. The focusing capability of the GRIN fiber 103 is a function of the diameter of the fiber. Using 125 micron GRIN fiber 103, to match the diameter of the SMF 110, the focus point is limited to 1-1.5 mm from the tip of the fiber. In imaging catheters where the fiber is deployed in the middle of the catheter, significant portion of the Rayleigh range of the beam could be lying inside the catheter. This reduces the imaging depth within which the imaging catheter is able to maintain high resolution.


Described herein are apparatuses, including tip assemblies for OCT (common path) imaging systems, and methods of making an using them, that may address the issues raised above.


SUMMARY OF THE DISCLOSURE

In general, described herein are OCT apparatuses (including devices and systems) that include a lens assembly that is, or is capable of being, positioned at distal tip of an optical fiber to provide common-path OCT imaging. The lens assembly is typically an anamorphic lens assembly.


In some embodiments, the anamorphic lens assembly has a lens body, and a first surface coupled to the optical fiber through which light from the optical fiber may pass into the lens body so that it can be reflected from a second, reflective, surface at an angle, to direct light out of the lens assembly and into a tissue (e.g., at a 45 degree angle). The second, reflective, surface may have a compound radius so that the beam profile of the light beam from the optical fiber is made approximately circular as it exits the lens assembly (e.g., out of a third, flat, surface that is perpendicular to the direction of the beam) reflected from the second surface).


In other embodiments, the anamorphic lens assembly has a concave proximal surface that is reflective and includes a compound surface to reflect light therefrom.


The lens assemblies described herein may be used as part of a catheter capable of OCT imaging. For example, a catheter for optical coherence tomography (OCT) may include: an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber, the lens assembly, wherein the optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.


As mentioned, the lens assembly may be an anamorphic lens assembly, refractive or reflective, e.g., having non-uniform or different magnifications or radii of curvatures along the two axes perpendicular to each other (e.g., the axis perpendicular to the path of light traveling through the lens body). In some variations, the anamorphic lens may refer specifically to the compound radii of curvature of the mirror portion. In other variations, the anamorphic lens may refer to a mirror having continuously changing or different radii of curvature between the two perpendicular axes.


In any of the variations described herein, the lens assembly (e.g., the first surface of the lens assembly) may be connected to the distal end of the optical fiber by a layer of epoxy.


In general, some embodiments, the first surface (the surface immediately opposite the distal end of the optical fiber) may be at an angle relative to the distal end (out of which the light passes) of between about 2 degrees and 40 degrees relative to the distal end of the optical fiber, e.g., the angle may be between about 5 degrees and 13 degrees, between about 2 degrees and 20 degrees, between 6 degrees and 10 degrees, about 8 degrees, etc.). Further, the second (reflective, or mirrored) surface is angled relative to the distal end of the optical fiber, so that light traveling to/from the distal end of the optical fiber, after passing the first surface of the lens body, is reflected by the second surface and directed laterally out of the lens. For example, the second surface may be at an angle of between about 10 degrees and about 60 degrees (e.g., 20 degrees and 50 degrees, 30 degrees and 50 degrees, 40 degrees and 50 degrees, about 45 degrees, etc.) relative to the distal end of the optical fiber.


In some embodiments, the reflective proximal surface can be angled relative to the distal end of the optical fiber, so that light traveling to/from the distal end of the optical fiber and impinging on the proximal surface is reflected and directed laterally out of the lens. For example, the proximal surface may be at an angle of between about 10 degrees and about 60 degrees (e.g., 20 degrees and 50 degrees, 30 degrees and 50 degrees, 40 degrees and 50 degrees, about 45 degrees, etc.) relative to the distal end of the optical fiber


The reflective second surface may be formed by coating (and/or attaching) a reflective material to the outer face of the second surface. The reflective material coating the second surface may be coated at a thickness that is configured to reflect more than 70% (e.g., more than 75%, more than 80%, more than 85%, more than 90%, more than 95%, etc.) of light. Any appropriate reflective material may be used. For example, the reflective material may comprise gold, silver, platinum, etc.


In general, the reflective surfaces may comprise a compound radius, e.g., a compound radius having a different radius in an x and a y axis. The compound radius may be configured so that light (e.g., a beam of light) reflecting off of the second surface has a beam profile that is more circular when it exits the lens body than when it entered the lens body.


The lens (e.g., the lens body) may be formed of any material, particularly materials that may be molded. For example, the lens body may be formed of a polycarbonate material having a refractive index that is mismatched relative to the refractive index of the optical fiber. Thus, for example, a secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly may be less than −60 dB. Further, the reference interface may provide a reference reflection of between about −28 and about −42 dB.


Any of the lens apparatuses, and/or any of the catheters including such lens apparatuses, described herein may be configured as a system including a light source and receiving electronics which may include a processor for generating OCT images. For example, a system for optical coherence tomography (OCT) may include: a source of optical radiation, an optical fiber extending distally to proximally, and a lens assembly optically coupled with a distal end of the optical fiber, wherein the optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a reference interface between the distal end of the optical fiber and the first surface, and from a target. The system can further include receiving electronics configured to receive the optical radiation reflected from the reference interface and the target and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.


Also described herein are method of takin OCT images including passing light from an optical fiber and into or off of a lens apparatus as described herein, The method can include creating minimal (e.g., less than −55 dB) secondary reflection results. The method may also include reflecting the light (beam) from the reflective surface at an angle of between about 30 degrees and 60 degrees (e.g., approximately 45 degrees) so that it projects laterally out of the device and into the tissue, then collecting light returning from the tissue and passing it back through the lens body and into the fiber optic, where it can be collected and processed (e.g., using a receiver and/or processor) to form an optical coherence tomographic image.


In general, in one embodiment, a catheter system for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber. The lens assembly includes a lens body having a first surface that is opposite from and at an angle relative to the distal end of the optical fiber and a second surface distal to the first surface. The second surface is coated with a reflective material so that light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.


In general, in one embodiment, a catheter system for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber. The lens assembly includes a lens body having a first surface that is opposite from and at an angle relative to the distal end of the optical fiber and a second surface distal to the first surface. The second surface has a compound radius having a first radius along a first axis that is different from a second radius along a second axis. That light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.


In general, in one embodiment, a catheter system for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly having a first refractive index optically coupled with a distal end of the optical fiber by an interface medium. The interface medium has a second refractive index. The first refractive index and the second refractive index differ by 0.02 or less. The lens assembly includes a lens body having a first surface that is opposite from the distal end of the optical fiber and a second surface distal to the first surface. Light passing from the distal end of the optical fiber through the first surface and into the lens body reflects off of the second surface and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the interface medium.


These and other embodiments can include one or more of the following features. The lens assembly can be an anamorphic lens assembly. The catheter system can further include an interface medium connecting the distal end of the optical fiber and the first surface. The interface medium can be an epoxy. The lens assembly can have a first refractive index and the interface medium can have a second refractive index, wherein the first refractive index and the second refractive index can differ by 0.02 or less. The first surface can be at an angle of 8 degrees or more relative to the distal end of the optical fiber. A tangent of the second surface can be at an angle of between about 40 degrees and 50 degrees relative to a longitudinal axis of the fiber. The catheter system can further include a reflective coating on the second surface. The reflective coating can have a thickness that is configured to reflect more than 80% of light. The reflective coating can be gold. The reflective material can be dielectric. The second surface can include a compound radius. The second surface can include a compound radius having a first radius along a first axis that is different than a second radius along a second axis. The lens body can include a polycarbonate material. A secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly can be less than −60 dB. The reference interface can provide a reference reflection of between −28 and −42 dB. The second surface can be concave relative to the light passing from the distal end of the optical fiber. An exit surface of the lens assembly can be angled by 8 degrees or more relative to a central longitudinal axis of the optical fiber. The reflective coating can have an optical density of greater than or equal to 3.0. A radius of curvature of the second surface can be between 0.2 mm and 1.5 mm. The catheter system can further include a source of optical radiation configured to provide the light, and a reflective coating on the second surface can have a thickness of at least ⅙ of an excitation wavelength of the source of optical radiation. The catheter system can further include a source of optical radiation, receiving electronics configured to receive optical radiation reflected from the reference interface and the target, and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.


In general, in one embodiment, a catheter for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber by an interface medium. The lens assembly includes a lens body having a concave proximal surface that is opposite from and at an angle relative to the distal end of the optical fiber. The proximal surface has a compound radius having first radius along a first axis that is different from a second radius along a second axis. The proximal surface includes a reflective material configured to so that at least 90% light passing from the distal end of the optical fiber through the lens assembly reflects off of the proximal surface. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the proximal surface.


This and other embodiments can include one or more of the following features. The interface medium can be an epoxy. A tangent of the proximal surface can be at an angle of between about 40 degrees and 50 degrees relative to a longitudinal axis of the fiber. The reflective material can include a reflective coating on the proximal surface. The reflective coating can be gold. The reflective material can be dielectric. The lens body can include a polycarbonate material. A secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly can be less than −60 dB. The reference interface can provide a reference reflection of between −28 and −42 dB. The reflective coating can have an optical density of greater than 3.0. A radius of curvature of the proximal surface can be between 0.2 mm and 1.5 mm. The catheter system can further include a source of optical radiation configured to provide the light, wherein a reflective coating on the proximal surface can have a thickness of at least ⅙ of an excitation wavelength of the source of optical radiation. The catheter system can further include a source of optical radiation, receiving electronics configured to receive optical radiation reflected from the reference interface and the target, and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.


In general, in one embodiment, a catheter for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber. The lens assembly includes a lens body having a first surface that is opposite from and at an angle relative to the distal end of the optical fiber and a second surface distal to the first surface. The second surface is uncoated such that light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface by total internal reflection and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.


In general, in one embodiment, a catheter for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber by an interface medium. The lens assembly includes a lens body having a concave proximal surface that is opposite from and at an angle relative to the distal end of the optical fiber. The proximal surface has a compound radius having first radius along a first axis that is different from a second radius along a second axis. The proximal surface is uncoated such that light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface by total internal reflection and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the proximal surface.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIG. 1 is an example of a prior art apparatus including a separate lens (an optical fiber configured as a GRIN lens) coupled to the distal end of an optical fiber, embedded in epoxy into which a separate mirror element has also be embedded.



FIG. 2 is an example of a catheter including a lens assembly as described herein.



FIG. 3A is a schematic of a lens assembly within a portion of a catheter. FIG. 3B shows a side sectional view through the lens of FIG. 3A. FIG. 3C shows a side sectional view from the opposite side as FIG. 3B. FIG. 3D shows a sectional view from the end of FIG. 3A.



FIG. 4 shows another example of a catheter including a lens assembly as described herein.



FIGS. 5A and 5B show perspective views of an exemplary lens assembly. FIG. 3A shows the proximal surface while FIG. 3B shows the distal surface.



FIG. 6A shows another embodiment of a catheter including a lens assembly as described herein. FIGS. 6B and 6C show perspective views of a lens assembly similar to that in FIG. 6A.



FIG. 7A shows an catheter with an exemplary pocket for placement of a lens assembly.



FIG. 7B shows a lens assembly built into a hypotube.



FIG. 8 is a graph illustrating the relative distances from the imaging tip versus beam diameter for each of a standard optical fiber, GRIN fiber and the improved lens apparatus as described herein, relative to beam diameter. As shown the beam diameter is much finer (smaller) for a much larger range of imaging tip distances, as compared to the prior art (GRIN) devices and devices without any lenses.



FIG. 9 shows an exemplary carbon dioxide cartridge.



FIG. 10 shows another embodiment of an exemplary carbon dioxide cartridge.



FIG. 11 shows an exemplary OCT system for use with a lens assembly as described herein.





DETAILED DESCRIPTION

Described herein are lens assemblies for use with an imaging device. Any of the lens assemblies described herein may be anamorphic lens assemblies (i.e., lens assemblies that are circularly nonsymmetric and have or produce unequal magnifications along two different axes, i.e., two different axes that are perpendicular to one another). The anamorphic lens, for example, can include two different radii along two different axes. The lens assemblies described herein may be used as part of any optical coherence tomography (OCT) device, and particularly as part of a common path OCT device, which may be included as part of a catheter or other device. The lens assembly may be, for example, placed in and/or on a distal tip of a catheter to: (1) direct the beam towards the imaging object and (2) focus the beam on the imaging object for improved image quality.


The lens assemblies described herein may be formed, e.g., using a mold. Thus, any of the lens assemblies may also be referred to as “molds” or “mold assemblies.” In some embodiments, the lens assemblies described herein may be made from polycarbonate material, such as Makrolon 2558. In some embodiments, the refractive index of the lens assembly can be close to the refractive index of the interface medium (e.g., epoxy) used to connect the lens assembly to the distal end of the imaging fiber optic.


Referring to FIG. 2, an imaging device 200 can include an optical fiber 215, e.g., an SMF fiber, used as part of a common path OCT system. The device 200 further includes an anamorphic lens 210 attached to the distal end 212 of the optical fiber 215 with an interface medium 202 (e.g., an adhesive or epoxy). The index of refraction of the core of the optical fiber 215 and the index of refraction of the interface medium 202 can be mismatched as described in U.S. patent application Ser. No. 14/400,140, filed on Nov. 10, 2014 (titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING”), the entirety of which is incorporated by reference herein. Further, the index of refraction of the lens 210 and the interface medium 202 can be closely matched (e.g., within 0.02, such as within 0.01 or within 0.001).


The distal surface 221 of the lens can have a compound radius (e.g., a different radius along the x-axis than along the y-axis). Further, the outer portion of the distal surface 221 can be convex (i.e., such that light hits the concave inner portion). The distal surface 221 can have a radius of curvature, for example, of between 0.2 mm and 1.5 mm.


Further, the distal surface 221 can include a mirror 201 attached or coated thereon. Thus, the mirror 201 can include a coating and/or attached layer on the distal surface 221 of the lens 210. The mirror can have a thickness that is configured to reflect more than 70% (e.g., more than 75%, more than 80%, more than 85%, more than 90%, more than 95%, etc.) of light. In one example, the mirror or coating can have a thickness of greater than or equal to 100 nm, such as greater than or equal to 200 nm or greater than or equal to 250 nm in thickness. In some embodiments, the mirror or coating can have an optical density of 3.0 or greater, such as 3.5 or greater. Any appropriate reflective material may be used for the mirror or coating. For example, the reflective material may include gold, silver, or platinum. Further, the mirror 201 can be angled at approximately 45 degrees, where the angle is defined as the angle off the intersection of the fiber optical axis the second surface (i.e., the angle between the optical axis and the tangent to the compound second surface at the intersection with the second surface).


In this embodiment, the proximal surface 211 of the lens 210 can be oriented substantially parallel to the distal surface 212 of the optical fiber. Further, the outer surface 217 of the lens 210 can be substantially parallel to the axis of the fiber 215 (and therefore substantially perpendicular to the proximal surface 211 of the lens and the distal surface 212 of the optical fiber). In one embodiment, surfaces 211, 217 can be substantially flat. In another embodiment, the surfaces can be slightly curved with a radius of curvature of 0.1 inches or more.


In use, light from the light source can pass through the optical fiber 215. At the interface of the distal end 212 of the optical fiber and the interface medium 202, some of the light will be reflected back so as to create the reference reflection. The rest of the light can pass from the distal end 212 of the optical fiber through the interface medium 202, and through the proximal surface 211 of the lens. Because the indices of refraction of the fiber and the interface medium are closely matched, only a minimal amount (e.g., less than −55 dB) of light will be reflected back from the surface 211. The light can thus travel through the lens 210 and impinge on the mirror 201. Because of the 45 degree angle and the compound surface of the mirror 201, the light can be reflected perpendicular to the longitudinal axis of the fiber 315 with a beam profile 213 that is close to circular when it exits the outer surface 217 of the lens 210.


As shown in FIG. 2, the fiber 215 can include a stripped section 205 (i.e., a section that does not include a coating, such as a polyimide coating). In contrast to the prior art designs (e.g., device 100 of FIG. 1), the device 200 can include a much smaller fragile section that is made only of the stripped section 205 (i.e., it does not include a GRIN lens). Further, in contrast to the device 100, the device 200 can include a combined lens and reflecting element (i.e., both can be built into lens 210).



FIGS. 3A-3D illustrate another device 300 including an anamorphic lens 310. The lens 310 is similar to lens 210 except that the proximal surface 311 is lens is angled 2-20 degrees, such as greater than or equal to 8 degrees, relative to the distal end 311 of the optical fiber 315. The relative angle can be obtained by cleaving the distal end of the fiber at an angle and/or by cutting the proximal surface 311 at an angle. Because the surface 311 is angled relative to the distal end 311 of the optical fiber, the refractive indices of the interface medium 302 and the lens 310 can be chosen to be further apart from one another (i.e., can be greater than 0.01 or 0.02). The angle between the distal end of the optical fiber and the proximal surface 311 can ensure that only a minimal amount (e.g., less than −55 dB) of light will be reflected back from the surface 311 while allowing flexibility in the choice of interface medium (e.g., adhesive or epoxy) used to attach the lens 310 to the optical fiber 315.


Referring to FIGS. 3C-3D, in an exemplary embodiment of a lens 310, a first radius (R1) of the anamorphic lens can be 0.0433 inches while a second radius (R2) of the anamorphic lens can be 0.0229 inches. The angle of the proximal surface 311 can be 8 degrees relative to a distal end of the fiber while an angle of the outer surface 317 can be 8 degrees relative to an axis that is parallel with the longitudinal axis of the fiber. In another embodiment, R1 can be 0.0276 inches, and R2 can be 0.0269 inches, which can result in focusing the beam closer within the target. Further, as shown, the distal surface 321 can be angled at approximately 45 degrees relative to the longitudinal axis of the optical fiber (i.e., the angle between the optical axis and the tangent to the compound second surface at the intersection with the second surface).



FIG. 4 illustrates yet another device 400 including an anamorphic lens 410. The lens 410 is similar to lens 310 except that the outer surface 417 is angled relative to the longitudinal axis of the fiber. That is, the outer surface 417 can have an angle of between 2-20 degrees, such as 8 degrees or more, relative to an axis that is parallel to the axis of the fiber 417. Angling the surface 417 by 8 degrees or more advantageously ensures that a minimal secondary reflection is created by the surface 417 during imaging. In some embodiments, the surface 417 can be angled so as to make a 90 degree angle with the proximal surface 411. In other embodiments, the surface 417 can be angled in the opposite direction and/or can be angled by a different amount than the proximal surface 411 so as to prevent the formation of a 90 degree angle (thereby helping to prevent back-reflection into the optical fiber 415).



FIGS. 5A-5B show an embodiment of an anamorphic lens 510 similar to lens 410. In this embodiment, however, a circle 599a, 599b is drawn on each surface 521, 511, to show a focal area of each of the surfaces 521, 511. The circles 599a,b thus indicate the desired position of the beam when it hits the surfaces 521, 511. Ideally, the beam hits within circle 599b at an intersection of both optical axes (e.g., along R1 and R2). Further, the circles 599a,b can have a larger diameter than the diameter of the fiber to provide tolerance for placement of the fiber relative to the lens 510. For example, the circles 599a,b can have a diameter of 10-100 microns. The optical density and/or thickness of the coating can be configured so as to provide the desired reflections regardless of where the light beam is positioned within circle 599b. Accordingly, the placement of the optical fiber relative to the lens assembly 510 can be within a set tolerance, such as to allow movement within 50 microns of center of the circle 599b.



FIGS. 6A-6C illustrate another device 600 including an anamorphic lens 610. The lens 610 includes a proximal surface 611 that is both coated with a reflective coating, such as gold (as described above) and that has compound radii (i.e., is anamorphic). During use of this embodiment, the light thus does not travel through the lens, but instead immediately reflects off of the surface 611. The surface 611 can be concave and can have radii and/or a radius of curvature that are approximately the same as described above with respect to the distal surface 321.


Thus, as discussed above, the SMF-GRIN and mirror assembly required for many prior art devices can be replaced with a single anamorphic lens assembly as described herein.


In some embodiments, the anamorphic lenses described herein can be made of polycarbonate.


Further, in some embodiments, the lens assemblies described herein can be molded. Molding a material, such as a polycarbonate, can be relatively inexpensive and easy to make, simplifying the manufacturing process and lowering the cost for making imaging assemblies.


Referring to FIG. 7A, in some embodiments, the formed lens assembly can be dropped into a crevice 777 or hole in the device housing 709, and the hole can then be filled with the interface medium. Referring to FIG. 7B, in some embodiments, the formed lens assembly can be integral with a hypotube 787 having an elongate channel 788 extending therethrough. The optical fiber can then be placed within the channel 788 and the interface medium used to attach the fiber to the lens 710.


The interface mediums described herein can be, for example, an epoxy, such as a UV-curing epoxy.


As mentioned and illustrated, the use of the anamorphic lens assemblies described herein may shorten the length of the distal tip of the devices in which the assemblies are used. The length of the stripped section of the fiber may be much smaller, so the distal imaging and therapeutic housing can be made much smaller.


The lens assemblies described herein can have significantly better focusing capability suited to the geometry of a catheter. For example, the radius of curvature of the anamorphic lens structures described herein may be such that the focus is a preferred (further) distance away from the housing. FIG. 8 shows examples of a range of beam diameters relative to the distance from the imaging tip for an OCT catheter without a lens 801, with a GRIN fiber lens 803, and with the anamorphic lens apparatuses described herein 805. In this example, the beam diameter with 0 being the edge of the housing.


In some embodiments, the lens assemblies described herein can themselves cause the reflection of the light beam into the tissue. That is, the reflective surfaces can be uncoated, and the reflection can be caused by a total internal reflection resulting from the mismatch of the refractive indices between the lens material and the interface medium and/or air surrounding the lens. In such embodiments, the refractive index of the lens material can be high, such as 1.0 or greater, 1.2 or greater, 1.5 or greater, or 1.7 or greater. Further, in embodiments where light travels through the lens, the distal surface of the lens can be bordered by air to ensure total internal reflection.


In some embodiments, the reference reflection can be made by a surface other than the optical fiber/interface medium surface. For example, the reference reflection can be made by the proximal or distal surfaces of the lens assembly and/or by the outer surface of the lens assembly. In such an embodiment, the indices of refraction of the interface medium and the core of the optical fiber can be closely matched (e.g., within 0.02) in order to provide only minimal secondary reflection at that interface.


The lens assemblies described herein can be used with a variety of different imaging catheters. For example, the lens assemblies can be used with: U.S. patent application Ser. No. 12/829,277, filed Jul. 1, 2010, titled “ATHERECTOMY CATHETER WITH LATERALLY-DISPLACEABLE TIP,” now U.S. Patent Application Publication No. 2011/0004107; U.S. patent application Ser. No. 12/829,267, filed Jul. 1, 2010, titled “CATHETER-BASED OFF-AXIS OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM,” now U.S. Pat. No. 9,125,562; U.S. patent application Ser. No. 13/175,232, filed Jul. 1, 2011, titled “ATHERECTOMY CATHETERS WITH LONGITUDINALLY DISPLACEABLE DRIVE SHAFTS,” now U.S. Pat. No. 9,345,510; U.S. patent application Ser. No. 13/433,049, filed Mar. 28, 2012, titled “OCCLUSION-CROSSING DEVICES, IMAGING, AND ATHERECTOMY DEVICES,” now U.S. Pat. No. 8,644,913; U.S. patent application Ser. No. 14/401,175, filed Nov. 14, 2014, titled “ATHERECTOMY CATHETERS WITH IMAGING,” now U.S. Patent Application Publication No. 2016/0141816; U.S. patent application Ser. No. 14/424,277, filed Feb. 26, 2015, titled “BALLOON ATHERECTOMY CATHETERS WITH IMAGING,” now U.S. Patent Application Publication No. 2015/0208922; U.S. patent application Ser. No. 14/776,750, filed Sep. 15, 2015, titled “CHRONIC TOTAL OCCLUSION CROSSING DEVICES WITH IMAGING, now U.S. Patent Application Publication No. 2016/0029902; U.S. patent application Ser. No. 15/072,272, filed Mar. 16, 2016, titled “ATHERECTOMY CATHETERS DEVICES HAVING MULTI-CHANNEL BUSHINGS,” now U.S. Patent Application Publication No. 2016/0192962; U.S. patent application Ser. No. 15/076,568, filed Feb. 5, 2015, titled “ATHERECTOMY CATHETERS AND OCCLUSION CROSSING DEVICES;” and International Patent Application No. PCT/US2015/039585, filed Jul. 8, 2015, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now International Patent Publication No. WO 2016/007652, the entireties of which are incorporated by reference.


The lens assemblies described herein can be used, for example, as part of an optical coherence tomography (OCT) system. Referring to FIG. 11, the system 1100 can therefore include a source of optical radiation 1122, a common path optical fiber 1115 (e.g., extending through a catheter elongate body), the lens assembly 1110, the interface medium or epoxy 1102, and a detector 1130 configured to receive the optical radiation reflected from the reference interface and the target 1114. The system 1100 can further include a processor to generate an image of the target based upon the optical radiation received by the receiving electronics. As is further shown in FIG. 11, a Faraday isolation device 1112, such as a Faraday Effect optical circulator, can be used to separate the paths of the outgoing light source signal and the target and reference signals returning from the distal end of the fiber. Exemplary OCT systems with which the lens assembly can be used are further described in U.S. patent application Ser. No. 14/400,140, filed on Nov. 10, 2014 (titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING”), the entirety of which is incorporated by reference herein.


In some embodiments, a secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly is less than −60 dB. Further, in some embodiments, the reference interface provides a reference reflection of between −28 and −42 dB.


Also described herein are carbon dioxide supply cartridges that can be used, for example, to inflate a balloon of a balloon catheter.



FIG. 9 shows a single-use carbon dioxide supply cartridge or device 900. The device 900 includes a cylinder 901 filled with carbon dioxide and a valve assembly 903. In one embodiment, the cylinder 901 and the valve assembly 903 can be twisted relative to one another in order to open the cylinder and pressure the valve assembly 903. For example, the cylinder 901 can have a threaded male portion 905 while the valve assembly 903 can include a threaded female portion 907. The valve assembly 903 can further include a piercing element, such as a needle, configured to break a seal on the cylinder 901 when the threaded portions 905, 907 are connected together. The valve assembly 903 can further include a rotational valve 919 configured to control or restrict flow of the gas therethrough. Further, a check valve 911 can be configured to control the maximum inflation pressure. For example, the check valve 911 can limit the inflation pressure to 15 psi. A catheter connection 909 can mechanically connect to the catheter and provide a flow path for the carbon dioxide from the device 900 to the balloon.



FIG. 10 shows another embodiment of a single-use carbon dioxide supply device 1000 with similar features as device 900.


The carbon dioxide supply devices 900, 1000 can be used with a variety of different balloon catheters. For example, the devices 900, 1000 can be used with balloon atherectomy catheters, such as those described in International Patent Application No. PCT/US2013/032494, filed Mar. 15, 2013, titled “BALOON ATHERECTOMY CATHETERS WITH IMAGING,” and International Patent Application No. PCT/US2015/014613, filed Feb. 5, 2015, titled “ATHERECTOMY CATHETERS AND OCCLUSION CROSSING DEVICES,” incorporated by reference herein in their entireties. The carbon dioxide supply device 100 can further be used, for example, with balloon angioplasty catheters. Advantageously, the carbon dioxide supply devices 900,1000 can be a single-use sterile product.


Although described as a carbon dioxide supply, other inflation gases can be used in devices 900, 1000.


When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.


Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.


Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.


Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.


As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.


Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.


The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.

Claims
  • 1. A catheter for optical coherence tomography (OCT), comprising: an elongate catheter body;an optical fiber in the elongate catheter body; anda lens assembly, the lens assembly comprising: a lens body having an elongate channel therein, the elongate channel holding a distal end of the optical fiber and filled with an interface medium;a concave lens surface at a distal end of the lens body, wherein the concave lens surface is positioned opposite from and at an angle relative to the distal end of the optical fiber, wherein the concave lens surface has a compound radius having first radius along a first axis that is different from a second radius along a second axis;wherein the optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface formed by the interface medium.
  • 2. The catheter of claim 1, wherein the reference interface is formed between the interface medium and the distal end of the optical fiber.
  • 3. The catheter system of claim 1, wherein the interface medium is an epoxy.
  • 4. The catheter system of claim 1, wherein a tangent of the concave lens surface is at an angle of between about 40 degrees and 50 degrees relative to a longitudinal axis of the optical fiber.
  • 5. The catheter system of claim 1, further comprising a reflective coating on the concave lens surface.
  • 6. The catheter system of claim 5, wherein the reflective coating comprises gold.
  • 7. The catheter system of claim 5, wherein the reflective coating comprises a dielectric.
  • 8. The catheter system of claim 5, wherein the reflective coating has an optical density of greater than 3.0.
  • 9. The catheter system of claim 1, wherein the lens assembly comprises a polycarbonate material.
  • 10. The catheter system of claim 5, further comprising a source of optical radiation, wherein the reflective coating has a thickness of at least ⅙ of an excitation wavelength of the source of optical radiation.
  • 11. The catheter system of claim 1, wherein a secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly is less than −60 dB.
  • 12. The catheter system of claim 1, wherein the reference interface provides a reference reflection of between −28 and −42 dB.
  • 13. The catheter system of claim 1, wherein a radius of curvature of the concave lens surface is between 0.2 mm and 1.5 mm.
  • 14. The catheter system of claim 1, further comprising a source of optical radiation, receiving electronics configured to receive optical radiation reflected from the reference interface and the target, and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.
  • 15. A method of generating an optical coherence tomography (OCT) image, comprising: passing light from an optical fiber to a concave lens surface, wherein a distal end of the optical fiber is positioned within an elongate channel of a lens assembly, and wherein the concave lens surface is at a distal end of the lens assembly and has a compound radius having first radius along a first axis that is different from a second radius along a second axis;reflecting light from the concave lens surface into tissue;collecting light returning from the tissue and passing it back through the lens assembly and into the optical fiber; andgenerating an OCT image with the light returning from the tissue.
  • 16. The method of claim 15, further comprising collecting light returned from an interface medium that holds the distal end of the optical fiber in the channel, wherein the step of generating an OCT image further comprises generating the OCT image with light returning from the interface medium.
  • 17. The method of claim 15, wherein the step of reflecting light comprises reflecting light at an angle of between about 30 degrees and 60 degrees so that it projects laterally into the tissue.
  • 18. The method of claim 15, wherein a tangent of the concave lens surface is at an angle of between about 40 degrees and 50 degrees relative to a longitudinal axis of the optical fiber.
  • 19. The method of claim 15, wherein a radius of curvature of the concave lens surface is between 0.2 mm and 1.5 mm.
  • 20. The method of claim 15, wherein the interface medium is an epoxy.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/741,928, filed on Jan. 4, 2018, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” which is a U.S. National Phase Application Under 35 U.S.C. § 371 of International Application No. PCT/US2016/42152, filed on Jul. 13, 2016, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” which claims priority to U.S. Provisional Patent Application No. 62/191,956, filed Jul. 13, 2015, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” and U.S. Provisional Patent Application No. 62/191,986, filed Jul. 13, 2015 and titled “CARBON DIOXIDE CARTRIDGE FOR BALLOON CATHETER,” each of which is incorporated by reference in its entirety. This application may be related to U.S. patent application Ser. No. 14/400,140, filed on Nov. 10, 2014 (titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING”), which is incorporated by reference in its entirety.

US Referenced Citations (515)
Number Name Date Kind
3367727 Ward et al. Feb 1968 A
3908637 Doroshow Sep 1975 A
4178935 Gekhaman et al. Dec 1979 A
4487206 Aagard Dec 1984 A
4527553 Upsher Jul 1985 A
4552554 Gould et al. Nov 1985 A
4611600 Cohen Sep 1986 A
4621353 Hazel et al. Nov 1986 A
4639091 Huignard et al. Jan 1987 A
4651753 Lifton Mar 1987 A
4654024 Crittenden et al. Mar 1987 A
4681106 Kensey et al. Jul 1987 A
4686982 Nash Aug 1987 A
4691708 Kane Sep 1987 A
4771774 Simpson et al. Sep 1988 A
4841977 Griffith et al. Jun 1989 A
4857046 Stevens et al. Aug 1989 A
4920961 Grossi et al. May 1990 A
4926858 Gifford, III et al. May 1990 A
5000185 Yock Mar 1991 A
5018529 Tenerz et al. May 1991 A
5041082 Shiber Aug 1991 A
5047040 Simpson et al. Sep 1991 A
5085662 Willard Feb 1992 A
5099850 Matsui et al. Mar 1992 A
5178153 Einzig Jan 1993 A
5182291 Gubin et al. Jan 1993 A
5190050 Nitzsche Mar 1993 A
5192291 Pannek, Jr. Mar 1993 A
5312415 Palermo May 1994 A
5312425 Evans et al. May 1994 A
5321501 Swanson et al. Jun 1994 A
5333142 Scheps Jul 1994 A
5358472 Vance et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5372560 Lary Dec 1994 A
5383460 Jang et al. Jan 1995 A
5383467 Auer et al. Jan 1995 A
5425273 Chevalier Jun 1995 A
5429136 Milo et al. Jul 1995 A
5431673 Summers et al. Jul 1995 A
5437284 Trimble Aug 1995 A
5459570 Swanson et al. Oct 1995 A
5460168 Masubuchi et al. Oct 1995 A
5465147 Swanson Nov 1995 A
5507795 Chiang et al. Apr 1996 A
5517998 Madison May 1996 A
5556405 Lary Sep 1996 A
5607394 Andersen et al. Mar 1997 A
5620426 Braithwaite Apr 1997 A
5632754 Farley et al. May 1997 A
5632755 Nordgren et al. May 1997 A
5674232 Halliburton Oct 1997 A
5681336 Clement et al. Oct 1997 A
5690634 Muller et al. Nov 1997 A
5722403 McGee et al. Mar 1998 A
5728148 Bostrom et al. Mar 1998 A
5795295 Hellmuth et al. Aug 1998 A
5807339 Bostrom et al. Sep 1998 A
5830145 Tenhoff Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5843103 Wulfman Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5868778 Gershony et al. Feb 1999 A
5872879 Hamm Feb 1999 A
5904651 Swanson et al. May 1999 A
5907425 Dickensheets et al. May 1999 A
5935075 Casscells et al. Aug 1999 A
5938602 Lloyd Aug 1999 A
5938671 Katoh et al. Aug 1999 A
5951482 Winston et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5951583 Jensen et al. Sep 1999 A
5956355 Swanson et al. Sep 1999 A
5957952 Gershony et al. Sep 1999 A
5987995 Sawatari et al. Nov 1999 A
5997558 Nash Dec 1999 A
6001112 Taylor Dec 1999 A
6007530 Dornhofer et al. Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017359 Gershony et al. Jan 2000 A
6027514 Stine et al. Feb 2000 A
6032673 Savage et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6080170 Nash et al. Jun 2000 A
6106515 Winston et al. Aug 2000 A
6110164 Vidlund Aug 2000 A
6120515 Rogers et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6134002 Stimson et al. Oct 2000 A
6134003 Tearney et al. Oct 2000 A
6152938 Curry Nov 2000 A
6152951 Hashimoto et al. Nov 2000 A
6160826 Swanson et al. Dec 2000 A
6175669 Colston et al. Jan 2001 B1
6176871 Pathak et al. Jan 2001 B1
6183432 Milo Feb 2001 B1
6193676 Winston et al. Feb 2001 B1
6206898 Honeycutt et al. Mar 2001 B1
6228076 Winston et al. May 2001 B1
6241744 Imran et al. Jun 2001 B1
6283957 Hashimoto et al. Sep 2001 B1
6285903 Rosenthal et al. Sep 2001 B1
6290668 Gregory et al. Sep 2001 B1
6294775 Seibel et al. Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6307985 Murakami et al. Oct 2001 B1
6375615 Flaherty et al. Apr 2002 B1
6402719 Ponzi et al. Jun 2002 B1
6416527 Berg et al. Jul 2002 B1
6445939 Swanson et al. Sep 2002 B1
6445944 Ostrovsky Sep 2002 B1
6447525 Follmer et al. Sep 2002 B2
6451036 Heitzmann et al. Sep 2002 B1
6454717 Pantages et al. Sep 2002 B1
6454779 Taylor Sep 2002 B1
6482216 Hiblar et al. Nov 2002 B1
6482217 Pintor et al. Nov 2002 B1
6485413 Boppart et al. Nov 2002 B1
6497649 Parker et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6503261 Bruneau et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6517528 Pantages et al. Feb 2003 B1
6542665 Reed et al. Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6546272 MacKinnon et al. Apr 2003 B1
6551302 Rosinko et al. Apr 2003 B1
6563105 Seibel et al. May 2003 B2
6564087 Pitris et al. May 2003 B1
6565588 Clement et al. May 2003 B1
6572563 Ouchi et al. Jun 2003 B2
6572643 Gharibadeh Jun 2003 B1
6575995 Huter et al. Jun 2003 B1
6579298 Bruneau et al. Jun 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6629953 Boyd Oct 2003 B1
6638233 Corvi et al. Oct 2003 B2
6645217 MacKinnon et al. Nov 2003 B1
6657727 Izatt et al. Dec 2003 B1
6666874 Heitzmann et al. Dec 2003 B2
6687010 Horii Feb 2004 B1
6728571 Barbato Apr 2004 B1
D489973 Root et al. May 2004 S
6730063 Delaney et al. May 2004 B2
6758854 Butler et al. Jul 2004 B1
6760112 Reed et al. Jul 2004 B2
6800085 Selmon et al. Oct 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6845190 Smithwick et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6853457 Bjarklev et al. Feb 2005 B2
6856712 Fauver et al. Feb 2005 B2
6867753 Chinthammit et al. Mar 2005 B2
6879851 McNamara et al. Apr 2005 B2
6947787 Webler Sep 2005 B2
6961123 Wang et al. Nov 2005 B1
6970732 Winston et al. Nov 2005 B2
6975898 Seibel Dec 2005 B2
7068878 Crossman-Bosworth et al. Jun 2006 B2
7074231 Jang Jul 2006 B2
7126693 Everett et al. Oct 2006 B2
7172610 Heitzmann et al. Feb 2007 B2
7242480 Alphonse Jul 2007 B2
7261687 Yang Aug 2007 B2
7288087 Winston et al. Oct 2007 B2
7291146 Steinke et al. Nov 2007 B2
7297131 Nita Nov 2007 B2
7311723 Seibel et al. Dec 2007 B2
7344546 Wulfman et al. Mar 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7426036 Feldchtein et al. Sep 2008 B2
7428001 Schowengerdt et al. Sep 2008 B2
7428053 Feldchtein et al. Sep 2008 B2
7455649 Root et al. Nov 2008 B2
7474407 Gutin Jan 2009 B2
7485127 Nistal Feb 2009 B2
7488340 Kauphusman et al. Feb 2009 B2
7530948 Seibel et al. May 2009 B2
7530976 MacMahon et al. May 2009 B2
7538859 Tearney et al. May 2009 B2
7538886 Feldchtein May 2009 B2
7539362 Teramura May 2009 B2
7542145 Toida et al. Jun 2009 B2
7544162 Ohkubo Jun 2009 B2
7545504 Buckland et al. Jun 2009 B2
7555333 Wang et al. Jun 2009 B2
7577471 Camus et al. Aug 2009 B2
7583872 Seibel et al. Sep 2009 B2
7616986 Seibel et al. Nov 2009 B2
7637885 Maschke Dec 2009 B2
7674253 Fisher et al. Mar 2010 B2
7682319 Martin et al. Mar 2010 B2
7706863 Imanishi et al. Apr 2010 B2
7728985 Feldchtein et al. Jun 2010 B2
7729745 Maschke Jun 2010 B2
7734332 Sher Jun 2010 B2
7738945 Fauver et al. Jun 2010 B2
7753852 Maschke Jul 2010 B2
7771425 Dycus et al. Aug 2010 B2
7785286 Magnin et al. Aug 2010 B2
7813609 Petersen et al. Oct 2010 B2
7821643 Amazeen et al. Oct 2010 B2
7824089 Charles Nov 2010 B2
7840283 Bush et al. Nov 2010 B1
7944568 Teramura et al. May 2011 B2
7952718 Li et al. May 2011 B2
7972299 Carter et al. Jul 2011 B2
8059274 Splinter Nov 2011 B2
8062316 Patel et al. Nov 2011 B2
8068921 Prakash et al. Nov 2011 B2
8313493 Fisher Nov 2012 B2
8361097 Patel et al. Jan 2013 B2
8548571 He et al. Oct 2013 B2
8548603 Swoyer et al. Oct 2013 B2
8632557 Thatcher et al. Jan 2014 B2
8644913 Simpson et al. Feb 2014 B2
8647335 Markus Feb 2014 B2
8696695 Patel et al. Apr 2014 B2
8911459 Simpson et al. Dec 2014 B2
9119662 Moberg Sep 2015 B2
9125562 Spencer et al. Sep 2015 B2
9333007 Escudero et al. May 2016 B2
9345398 Tachibana et al. May 2016 B2
9345406 Spencer et al. May 2016 B2
9345510 Patel et al. May 2016 B2
9345511 Smith et al. May 2016 B2
9351757 Kusleika May 2016 B2
9498247 Patel et al. Nov 2016 B2
9498600 Rosenthal et al. Nov 2016 B2
9557156 Kankaria Jan 2017 B2
9572492 Simpson et al. Feb 2017 B2
9592075 Simpson et al. Mar 2017 B2
9642646 Patel et al. May 2017 B2
9788790 Black et al. Oct 2017 B2
9854979 Smith et al. Jan 2018 B2
9918734 Patel et al. Mar 2018 B2
9949754 Newhauser et al. Apr 2018 B2
10052125 Rosenthal et al. Aug 2018 B2
10130386 Simpson et al. Nov 2018 B2
10244934 Tachibana et al. Apr 2019 B2
10335173 Carver et al. Jul 2019 B2
10342491 Black et al. Jul 2019 B2
10349974 Patel et al. Jul 2019 B2
10357277 Patel et al. Jul 2019 B2
10363062 Spencer et al. Jul 2019 B2
10470795 Patel et al. Nov 2019 B2
10548478 Simpson et al. Feb 2020 B2
10568520 Patel Feb 2020 B2
10568655 Simpson et al. Feb 2020 B2
10722121 Smith et al. Jul 2020 B2
10729326 Spencer et al. Aug 2020 B2
10860484 McKenna et al. Dec 2020 B2
10869685 Patel et al. Dec 2020 B2
20010005788 McGuckin, Jr. Jun 2001 A1
20010020126 Swanson et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020072706 Hiblar et al. Jun 2002 A1
20020082585 Carroll et al. Jun 2002 A1
20020082626 Donohoe et al. Jun 2002 A1
20020111548 Swanson et al. Aug 2002 A1
20020115931 Strauss et al. Aug 2002 A1
20020147459 Bashiri et al. Oct 2002 A1
20020158547 Wood Oct 2002 A1
20030002038 Mawatari Jan 2003 A1
20030028100 Tearney et al. Feb 2003 A1
20030032880 Moore Feb 2003 A1
20030045835 Anderson et al. Mar 2003 A1
20030095248 Frot May 2003 A1
20030097044 Rovegno May 2003 A1
20030120150 Govari Jun 2003 A1
20030120295 Simpson et al. Jun 2003 A1
20030125756 Shturman et al. Jul 2003 A1
20030125757 Patel et al. Jul 2003 A1
20030125758 Simpson et al. Jul 2003 A1
20030139751 Evans et al. Jul 2003 A1
20030181855 Simpson et al. Sep 2003 A1
20040002650 Mandrusov et al. Jan 2004 A1
20040039371 Tockman et al. Feb 2004 A1
20040057667 Yamada et al. Mar 2004 A1
20040059257 Gaber Mar 2004 A1
20040082850 Bonner et al. Apr 2004 A1
20040092915 Levatter May 2004 A1
20040093001 Hamada May 2004 A1
20040147934 Kiester Jul 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040181249 Torrance et al. Sep 2004 A1
20040186368 Ramzipoor et al. Sep 2004 A1
20040193140 Griffin et al. Sep 2004 A1
20040202418 Ghiron et al. Oct 2004 A1
20040220519 Wulfman et al. Nov 2004 A1
20040230212 Wulfman Nov 2004 A1
20040230213 Wulfman et al. Nov 2004 A1
20040236312 Nistal et al. Nov 2004 A1
20040243162 Wulfman et al. Dec 2004 A1
20040254599 Lipoma et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050020925 Kleen et al. Jan 2005 A1
20050043614 Huizenga et al. Feb 2005 A1
20050054947 Goldenberg Mar 2005 A1
20050075660 Chu et al. Apr 2005 A1
20050085708 Fauver et al. Apr 2005 A1
20050085721 Fauver et al. Apr 2005 A1
20050105097 Fang-Yen et al. May 2005 A1
20050141843 Warden et al. Jun 2005 A1
20050154407 Simpson Jul 2005 A1
20050159712 Andersen Jul 2005 A1
20050159731 Lee Jul 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177068 Simpson Aug 2005 A1
20050182295 Soper et al. Aug 2005 A1
20050187571 Maschke Aug 2005 A1
20050192496 Maschke Sep 2005 A1
20050197623 Leeflang et al. Sep 2005 A1
20050201662 Petersen et al. Sep 2005 A1
20050203553 Maschke Sep 2005 A1
20050222519 Simpson Oct 2005 A1
20050222663 Simpson et al. Oct 2005 A1
20050251116 Steinke et al. Nov 2005 A1
20060011820 Chow-Shing et al. Jan 2006 A1
20060032508 Simpson Feb 2006 A1
20060046235 Alexander Mar 2006 A1
20060049587 Cornwell Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060084911 Belef et al. Apr 2006 A1
20060109478 Tearney et al. May 2006 A1
20060135870 Webler Jun 2006 A1
20060173475 Lafontaine et al. Aug 2006 A1
20060229646 Sparks Oct 2006 A1
20060229659 Gifford et al. Oct 2006 A1
20060235262 Arnal et al. Oct 2006 A1
20060235366 Simpson Oct 2006 A1
20060236019 Soito et al. Oct 2006 A1
20060239982 Simpson Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060252993 Freed et al. Nov 2006 A1
20060264741 Prince Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20070010840 Rosenthal et al. Jan 2007 A1
20070015969 Feldman et al. Jan 2007 A1
20070015979 Redel Jan 2007 A1
20070035855 Dickensheets Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070038173 Simpson Feb 2007 A1
20070078469 Soito et al. Apr 2007 A1
20070078500 Ryan et al. Apr 2007 A1
20070081166 Brown et al. Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070106155 Goodnow et al. May 2007 A1
20070135712 Maschke Jun 2007 A1
20070167710 Unal et al. Jul 2007 A1
20070196926 Soito et al. Aug 2007 A1
20070219484 Straub Sep 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070255252 Mehta Nov 2007 A1
20070270647 Nahen et al. Nov 2007 A1
20070276419 Rosenthal Nov 2007 A1
20070288036 Seshadri Dec 2007 A1
20070299309 Seibel et al. Dec 2007 A1
20080004643 To et al. Jan 2008 A1
20080004644 To et al. Jan 2008 A1
20080004645 To et al. Jan 2008 A1
20080004646 To et al. Jan 2008 A1
20080015491 Bei et al. Jan 2008 A1
20080027334 Langston Jan 2008 A1
20080033396 Danek et al. Feb 2008 A1
20080045986 To et al. Feb 2008 A1
20080049234 Seitz Feb 2008 A1
20080058629 Seibel et al. Mar 2008 A1
20080065124 Olson Mar 2008 A1
20080065125 Olson Mar 2008 A1
20080065205 Nguyen et al. Mar 2008 A1
20080095421 Sun et al. Apr 2008 A1
20080103439 Torrance et al. May 2008 A1
20080103446 Torrance et al. May 2008 A1
20080103516 Wulfman et al. May 2008 A1
20080132929 O'Sullivan et al. Jun 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080146942 Dala-Krishna Jun 2008 A1
20080147000 Seibel et al. Jun 2008 A1
20080154293 Taylor et al. Jun 2008 A1
20080177138 Courtney et al. Jul 2008 A1
20080186501 Xie Aug 2008 A1
20080221388 Seibel et al. Sep 2008 A1
20080228033 Tumlinson et al. Sep 2008 A1
20080243030 Seibel et al. Oct 2008 A1
20080243031 Seibel et al. Oct 2008 A1
20080262312 Carroll et al. Oct 2008 A1
20080275485 Bonnette et al. Nov 2008 A1
20090018565 To et al. Jan 2009 A1
20090018566 Escudero et al. Jan 2009 A1
20090018567 Escudero et al. Jan 2009 A1
20090024084 Khosla et al. Jan 2009 A1
20090024085 To et al. Jan 2009 A1
20090024191 Seibel et al. Jan 2009 A1
20090028407 Seibel et al. Jan 2009 A1
20090028507 Jones et al. Jan 2009 A1
20090043191 Castella et al. Feb 2009 A1
20090073444 Wang Mar 2009 A1
20090076447 Casas et al. Mar 2009 A1
20090093764 Pfeffer et al. Apr 2009 A1
20090099641 Wu et al. Apr 2009 A1
20090125019 Douglass et al. May 2009 A1
20090135280 Johnston et al. May 2009 A1
20090137893 Seibel et al. May 2009 A1
20090152664 Tian et al. Jun 2009 A1
20090185135 Volk Jul 2009 A1
20090196554 Irisawa Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090208143 Yoon et al. Aug 2009 A1
20090216180 Lee et al. Aug 2009 A1
20090221904 Shealy et al. Sep 2009 A1
20090221920 Boppart et al. Sep 2009 A1
20090235396 Wang et al. Sep 2009 A1
20090244485 Walsh et al. Oct 2009 A1
20090244547 Ozawa Oct 2009 A1
20090264826 Thompson Oct 2009 A1
20090284749 Johnson et al. Nov 2009 A1
20090292199 Bielewicz et al. Nov 2009 A1
20090306520 Schmitt et al. Dec 2009 A1
20090316116 Melville et al. Dec 2009 A1
20090318862 Ali et al. Dec 2009 A1
20100004544 Toida Jan 2010 A1
20100021926 Noordin Jan 2010 A1
20100049225 To et al. Feb 2010 A1
20100080016 Fukui et al. Apr 2010 A1
20100082000 Honeck et al. Apr 2010 A1
20100125253 Olson May 2010 A1
20100130996 Doud et al. May 2010 A1
20100217245 Prescott Aug 2010 A1
20100241147 Maschke Sep 2010 A1
20100253949 Adler Oct 2010 A1
20100292539 Lankenau et al. Nov 2010 A1
20100292721 Moberg Nov 2010 A1
20100312263 Moberg et al. Dec 2010 A1
20100317973 Nita Dec 2010 A1
20100324472 Wulfman Dec 2010 A1
20110023617 Yu et al. Feb 2011 A1
20110028977 Rauscher et al. Feb 2011 A1
20110040238 Wulfman et al. Feb 2011 A1
20110058250 Liu et al. Mar 2011 A1
20110060186 Tilson et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110092955 Purdy et al. Apr 2011 A1
20110106004 Eubanks et al. May 2011 A1
20110118660 Torrance et al. May 2011 A1
20110130777 Zhang et al. Jun 2011 A1
20110144673 Zhang et al. Jun 2011 A1
20110201924 Tearney et al. Aug 2011 A1
20110208222 Ljahnicky et al. Aug 2011 A1
20110257478 Kleiner et al. Oct 2011 A1
20110264125 Wilson et al. Oct 2011 A1
20110270187 Nelson Nov 2011 A1
20110295148 Destoumieux et al. Dec 2011 A1
20110301625 Mauch et al. Dec 2011 A1
20110319905 Palme et al. Dec 2011 A1
20120002928 Irisawa Jan 2012 A1
20120004506 Tearney et al. Jan 2012 A1
20120123352 Fruland et al. May 2012 A1
20120238869 Schmitt et al. Sep 2012 A1
20120259337 del Rio et al. Oct 2012 A1
20120289971 Segermark et al. Nov 2012 A1
20130035692 Sorensen et al. Feb 2013 A1
20130072787 Wallace et al. Mar 2013 A1
20130211221 Sunnarborg et al. Aug 2013 A1
20130223798 Jenner et al. Aug 2013 A1
20130223801 Bhagavatula et al. Aug 2013 A1
20130255069 Higashi et al. Oct 2013 A1
20130266259 Bhagavatula et al. Oct 2013 A1
20130287282 Yokota et al. Oct 2013 A1
20130317519 Romo et al. Nov 2013 A1
20130325003 Kapur et al. Dec 2013 A1
20140005534 He et al. Jan 2014 A1
20140128893 Guggenheimer et al. May 2014 A1
20140187949 Zhao et al. Jul 2014 A1
20140222042 Kessler et al. Aug 2014 A1
20140222047 Vreeman Aug 2014 A1
20140275996 Stigall Sep 2014 A1
20140291985 Cabrera et al. Oct 2014 A1
20140343410 Graf et al. Nov 2014 A1
20140371718 Alvarez et al. Dec 2014 A1
20150025310 Everingham et al. Jan 2015 A1
20150036146 Staloff Feb 2015 A1
20150141816 Gupta et al. May 2015 A1
20150146211 Bhagavatula et al. May 2015 A1
20150320975 Simpson et al. Nov 2015 A1
20160008025 Gupta et al. Jan 2016 A1
20160038030 Smith et al. Feb 2016 A1
20160144155 Simpson et al. May 2016 A1
20160262839 Spencer et al. Sep 2016 A1
20170238803 Kankaria Aug 2017 A1
20170238808 Simpson et al. Aug 2017 A1
20180042520 Patel et al. Feb 2018 A1
20180207417 Zung et al. Jul 2018 A1
20180364024 Baca Dec 2018 A1
20190021679 Christensen Jan 2019 A1
20190021760 Newhauser et al. Jan 2019 A1
20190029714 Patel et al. Jan 2019 A1
20190110809 Rosenthal et al. Apr 2019 A1
20190209206 Patel et al. Jul 2019 A1
20190313941 Radjabi Oct 2019 A1
20200029801 Tachibana et al. Jan 2020 A1
20200060718 Patel et al. Feb 2020 A1
20200069253 Black et al. Mar 2020 A1
20200069327 Patel et al. Mar 2020 A1
20200315654 Patel et al. Oct 2020 A1
20200323553 Fernandez et al. Oct 2020 A1
Foreign Referenced Citations (95)
Number Date Country
1875242 Dec 2006 CN
1947652 Apr 2007 CN
101601581 Dec 2009 CN
103027727 Apr 2013 CN
202006018883.5 Feb 2007 DE
0347098 Dec 1989 EP
0808638 Nov 1997 EP
0845692 Nov 2005 EP
1859732 Nov 2007 EP
2090245 Aug 2009 EP
2353526 Sep 2013 EP
2942028 Nov 2015 EP
S62-275425 Nov 1987 JP
03502060 Feb 1990 JP
05103763 Apr 1993 JP
06027343 Feb 1994 JP
H07184888 Jul 1995 JP
07308393 Nov 1995 JP
2002214127 Jul 2002 JP
2004509695 Apr 2004 JP
2004516073 Jun 2004 JP
2005114473 Apr 2005 JP
2005230550 Sep 2005 JP
2005249704 Sep 2005 JP
2005533533 Nov 2005 JP
2008175698 Jul 2006 JP
2006288775 Oct 2006 JP
2006313158 Nov 2006 JP
2006526790 Nov 2006 JP
2006326157 Dec 2006 JP
200783053 Apr 2007 JP
200783057 Apr 2007 JP
2007225349 Sep 2007 JP
2007533361 Nov 2007 JP
2008023627 Feb 2008 JP
2008128708 Jun 2008 JP
2008145376 Jun 2008 JP
2008183208 Aug 2008 JP
2008253492 Oct 2008 JP
200914751 Jan 2009 JP
2009509690 Mar 2009 JP
200978150 Apr 2009 JP
2009066252 Apr 2009 JP
2009201969 Sep 2009 JP
2010042182 Feb 2010 JP
2010518900 Jun 2010 JP
2011521747 Jul 2011 JP
2012143558 Aug 2012 JP
2012229976 Nov 2012 JP
2012533353 Dec 2012 JP
2013524930 Jun 2013 JP
2015533584 Nov 2015 JP
2016508758 Mar 2016 JP
20070047221 May 2007 KR
2185859 Jul 2002 RU
2218191 Dec 2003 RU
WO9117698 Nov 1991 WO
WO9923958 May 1999 WO
WO0054659 Sep 2000 WO
WO0115609 Mar 2001 WO
WO0176680 Oct 2001 WO
WO2006133030 Dec 2006 WO
WO2008005888 Jan 2008 WO
WO2008029506 Mar 2008 WO
WO2008042987 Apr 2008 WO
WO2008051951 May 2008 WO
WO2008065600 Jun 2008 WO
WO2008086613 Jul 2008 WO
WO2008087613 Jul 2008 WO
WO2009005779 Jan 2009 WO
WO2009006335 Jan 2009 WO
WO2009009799 Jan 2009 WO
WO2009009802 Jan 2009 WO
WO2009023635 Feb 2009 WO
WO2009024344 Feb 2009 WO
WO2009094341 Jul 2009 WO
WO2009140617 Nov 2009 WO
WO2009148317 Dec 2009 WO
WO2010039464 Apr 2010 WO
WO2010056771 May 2010 WO
WO2011044387 Apr 2011 WO
WO2011062087 May 2011 WO
WO2012057940 May 2012 WO
WO2012061935 May 2012 WO
WO2012123737 Sep 2012 WO
WO2012166332 Dec 2012 WO
WO2013033490 Mar 2013 WO
WO2013056262 Apr 2013 WO
WO2014077870 May 2014 WO
WO2014093148 Jun 2014 WO
WO2015074018 May 2015 WO
WO2015101747 Jul 2015 WO
WO2015120146 Aug 2015 WO
WO2015165736 Nov 2015 WO
WO2017007853 Jan 2017 WO
Non-Patent Literature Citations (23)
Entry
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005.
Bayer Material Science: ; Snap-Fit Joints for Plastics; 26 pages; retrieved from the Internet: ( https://web.archive.org/web/20121119232733if_/http://fab.cba.mit.edu:80/classes/S62.12/people/vernelle.noel/Plastic_Snap_fit_design.pdf) on Sep. 26, 2018.
Choma et al.; Sensitivity advantage of swept source and fourier domain optical coherence tomography; Optics Express; 11(18); pp. 2183-2189; Sep. 8, 2003.
De Boer et al.; Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography; Optics Letters; 28(21); pp. 2067-2069; Nov. 2003.
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987.
Gonzalo et al.; Optical coherence tomography patterns of stent restenosis; Am. Heart J.; 158(2); pp. 284-293; Aug. 2009.
Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages.
Leitgeb et al.; Performance of fourier domain vs time domain optical coherence tomography; Optics Express; 11(8); pp. 889-894; Apr. 21, 2003.
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990.
Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages.
Rollins et al.; Optimal interferometer designs for optical coherence tomography; Optics Letters; 24(21); pp. 1484-1486; Nov. 1999.
Schmitt et al.; A new rotational thrombectomy catheter: System design and first clinical experiences; Cardiovascular and Interventional Radiology; Springer-Verlag; 22(6); pp. 504-509; Nov. 1, 1999.
Sharma et al.; Common-path optical coherence tomography with side-viewing bare fiber probe for endoscopic optical coherence tomography; Rev. Sci. Instrum.; vol. 78; 113102; 5 pages; Nov. 6, 2007.
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages.
Shinkle et al.; Evaluation of stent placement and outcomes with optical coherence tomography; Interv. Cardiol.; 2(4); pp. 535-543; (manuscript version, 12 pages); Aug. 2010.
Stamper et al.; Plaque characterization with optical coherence tomography. Journal of the American College of Cardiology. 47(8); pp. 69-79; Apr. 18, 2006.
Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994.
Tanaka et al.; Challenges on the frontier of intracoronary imaging: atherosclerotic plague macrophage measurement by optical coherence tomography; Journal of Biomedical Optics; 15(1); pp. (011104-1)-(011104-8); Jan.-Feb. 2010.
Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010.
Smith et al.; U.S. Appl. No. 16/941,310 entitled “Chronic total occlusion crossing devices with imaging,” filed Jul. 28, 2020.
Spencer et al.; U.S. Appl. No. 16/943,446 entitled “Catheter-based off-axis optical coherence tomography imaaing system” filed Jul. 30, 2020.
Patel et al.; U.S. Appl. No. 17/046,066 entitled “Occlusion-crossing devices,” filed Oct. 8, 2020.
Simpson et al.; U.S. Appl. No. 17/075,548 entitled “Identification of elastic lamina to guide interventional therapy,” filed Oct. 20, 2020.
Related Publications (1)
Number Date Country
20210015367 A1 Jan 2021 US
Provisional Applications (2)
Number Date Country
62191986 Jul 2015 US
62191956 Jul 2015 US
Continuations (1)
Number Date Country
Parent 15741928 US
Child 16801047 US